# Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.

> **NCT06974474** · PHASE4 · RECRUITING · sponsor: **Fondazione Policlinico Universitario Campus Bio-Medico** · enrollment: 26 (estimated)

## Conditions studied

- Psoriasis Arthritis

## Interventions

- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT06974474
- **Lead sponsor:** Fondazione Policlinico Universitario Campus Bio-Medico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-18
- **Primary completion:** 2025-11-27
- **Final completion:** 2027-05-27
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06974474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06974474, "Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06974474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*